MedPage Today on MSN
FDA Approves At-Home Device for Treatment-Resistant Depression
The FDA approved a prescription at-home brain neuromodulation therapy as an adjunctive depression treatment for adults, maker ...
About 20% of U.S. adults experience major depression in their lifetime. For most people, symptoms improve within a few ...
The wearable device delivers electrical impulses through a headset that can be administered by the patient at home under physician oversight.
For decades, scientists have investigated the neurokinin-1 receptor (NK1R) as a potential target for treating major ...
An analysis of major depressive disorder, covering diagnostic criteria, prevalence statistics across demographics, and ...
A review of recent studies suggests exercise may treat depression as effectively as therapy or antidepressants, offering an ...
Researchers compared a traditional Chinese medicine, Yueju Pill, with a standard antidepressant and found both reduced ...
In a major shift for how mental health conditions might be treated, the US Food and Drug Administration (FDA) has approved ...
Depression, one of the most prevalent mental health disorders worldwide, is characterized by persistent feelings of sadness, ...
Communication with a spouse who is depressed requires listening skills, discernment, and self-control. Talking through ...
Fish oil pills rich in omega-3 fatty acids gained attention as a possible add-on treatment for depression, as a few studies ...
Radial reports that teen depression is prevalent yet under-treated. Effective options include therapy, antidepressants, and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results